Loading clinical trials...

Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules | Clinical Trials | Clareo Health

TERMINATEDPhase 3NCT05142904

Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

The purpose of this study is to compare treatment of hyperthyroidism with radiofrequency ablation or I-131 for solitary autonomous thyroid nodules.

Lead sponsor: Rijnstate Hospital•14 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment40

Start dateNov 2021

Last updatedJul 17, 2025

Condition

Thyroid Nodule, Toxic or With Hyperthyroidism Autonomous Thyroid Function Thyroid Nodule; Hyperthyroidism Radiofrequency Ablation Iodine Hyperthyroidism+1 more

Locations shown

Ziekenhuis Groep Twente

Almelo, Gelderland

Gelre Hospitals

Apeldoorn, Gelderland

Rijnstate Hospital

Arnhem, Gelderland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions